Skip to main content

Table 6 Effects of the study drugs on blood pressure (mmHg), HR (bpm) and plasma creatinine (μmol/L)

From: Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels

Parameters

High BNP group

Extra-high BNP group

 

Dobutamine (n = 30)

rhBNP (n = 28)

Dobutamine (n = 23)

rhBNP (n = 23)

 

Baseline

5 Days

Baseline

5 Days

Baseline

5 Days

Baseline

5 Days

SBP

119.3 ± 12.7

121.3 ± 12.0

122.9 ± 11.9

115.4 ± 12.4**

114.8 ± 11.9

116.0 ± 12.5

118.6 ± 13.0

113.2 ± 13.2**

DBP

72.4 ± 6.8

74.3 ± 5.3

73.5 ± 7.7

69.6 ± 7.9**

70.7 ± 6.7

71.8 ± 6.6

71.9 ± 6.5

68.7 ± 6.6**

HR

77.6 ± 12.5

80.3 ± 13.1

81.8 ± 11.1

83.9 ± 11.5

83.2 ± 13.9

85.7 ± 13.0

82.3 ± 12.4

84.6 ± 9.3

Cr

84.4 ± 29.8

79.3 ± 20.4

78.5 ± 31.9

80.9 ± 26.3

95.4 ± 24.4

90.3 ± 23.3

98.6 ± 30.1

105.5 ± 32.9

  1. Abbreviations: HR heart rate. Other abbreviations are same as in Table 1 and Table 2. Values are mean ± SD. **P < 0.01 (paired t- test) versus baseline.